The rapid spread of COVID-19 has created a new business reality. Especially for those involved with clinical trials, achieving key endpoints has become substantially harder. Many employees are required to work from home, clinical research partners may be pulled away from a trial to other priorities, and study participants may not even show up. At the same time, development timelines have to be met, or in some cases are now compressed. These challenges can seem overwhelming but there is a way to adapt and thrive.
To help you plan for the future of your program, we are joined by Rahul Chaturvedi, an expert in clinical development with 10+ years of experience. Join this webinar, we will discuss:
- Some of the ways clinical trials are being disrupted
- A framework for assessing risks to your clinical program
- Priorities for re-planning activities across the supply chain (clinical supply, regulatory, etc.)
- Shifting your mindset to take advantage of this time to strengthen your clinical program